Casdin Capital, LLC Nautilus Biotechnology, Inc. Transaction History

Casdin Capital, LLC

  • $1.29 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$4.45 - $6.21 $1 Million - $1.4 Million
-225,000 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$6.14 - $10.1 $1.69 Million - $2.78 Million
-275,000 Reduced 55.0%
225,000 $1.38 Million
Q2 2021

Aug 16, 2021
BUY
$9.04 - $14.19 $4.52 Million - $7.1 Million
500,000 New
500,000 $5.05 Million

Others Institutions Holding NAUT

# of Institutions
86
Shares Held
64.3M
Call Options Held
1.9K
Put Options Held
100
View Full List

About Nautilus Biotechnology, Inc.

NAUT Quotes by TradingView
  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $226M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Casdin Capital, LLC Portfolio

Follow Casdin Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email